Coagulase negative species of Staphylococcus are often associated with opportunistic hospital 2 acquired infections that arise from colonization of indwelling catheters. Here we show that the 3 anti-parasitic drug nitazoxanide (NTZ) and its active metabolite tizoxanide (TIZ) are inhibitory 4 to growth of Staphylococcus epidermidis and other staphylococci, including methicillin resistant 5
INTRODUCTION 1 4 impregnated catheters compared with non impregnated catheters; rifampin-minocycline coated 1 catheters compared with non-coated catheters; and rifampin-minocycline impregnated catheters 2 compared with chlorhexidine-silver sulfadiazine catheters (1, 20) . 3
Nitazoxanide (NTZ) is a 5-nitrothiazole therapeutic (see Figure 1 ) that is used to treat a 4 wide variety of parasitic and anaerobic bacterial infections (6) and is FDA approved for 5 treatment of Cryptosporidium parvum and Giardia intestinalis infections in adults and children 6 (8). The drug also shows efficacy against Clostridium difficile infections (22, 26) . Mechanistic 7 studies have shown that NTZ is a potent inhibitor of pyruvate: ferredoxin oxidoreductase 8 (PFOR) (9) and therefore is active against all organisms (anaerobic bacteria and parasites) 9 expressing this enzyme (28). Mechanistic studies revealed that the anionic form of the drug is 10 biologically active and a proton abstraction mechanism has been proposed (9). Such a generic 11 mechanism might account for the wide range of biological targets reported for this drug (9, 24, 12 25, 33) . 13
One of the original communications on the spectrum of action of NTZ indicated that the 14 drug was only active against Staphylococcus aureus under anaerobic conditions and the active 15 metabolite tizoxanide (TIZ) of NTZ was not active against staphylocci (6). In the present study 16 we explored the inhibitory nature of these inhibitors against strains of S. aureus and S. 17 epidermidis. Our studies show that NTZ as well as TIZ are inhibitory to aerobic growth of 18 staphylococcal species including MRSA strains of S. aureus (MIC 8-16 µg/ml). At sub-MIC 19 levels NTZ blocks biofilm formation by S. epidermidis and this inhibition can be reversed in a 20 dose dependent manner by zinc salts. While the function of accumulation associated protein 21 (Aap) in biofilm formation is zinc dependent (4), our studies rule out simple chelation as a 22
on August 29, 2017 by guest http://aac.asm.org/ Downloaded from 5 mechanism of drug action. Rather, NTZ appears to affect assembly or function of surface 1 components associated with biofilm production. 2 3
MATERIALS AND METHODS 4
Bacterial strains and growth conditions. Bacterial strains used in this study are listed in 5 Table 1 . Unless otherwise specified, strains were grown in Trypticase soy broth or agar (TSB or 6 TSA, respectively) at 37 o C with shaking for liquid cultures. All strains were stored at -80 o C in 7 15% glycerol. 8
Identification of S. epidermidis isolates from catheter related bloodstream infections. 9
Infection-causing strains (ICS) of S. epidermidis were obtained from individuals with a long-10 term intravenous catheter and a catheter-related bloodstream infection (CRBSI), defined by more 11 than one blood culture and a concomitant catheter tip culture with CoNS. Medical records for 12 these patients were reviewed to confirm that the patient exhibited clinical manifestations of a 13 systemic inflammatory response syndrome, the absence of another focus of infection, and 14 resolution of SIRS within 48 h of catheter removal. 15
Species identification was performed by one of two methods: either by using the API Staph 16 system (BioMerieux, Durham, NC), according to the manufacturer's instructions, or by genetic 17 testing. The latter was performed by a combination of two methods: PCR identification of the S. 18 epidermidis specific gene serp0107 (16) and PCR restriction fragment length polymorphism 19 (RFLP) analysis of the Staphylococcus tuf gene (15). Genomic DNA was prepared by 20 suspending an individual bacterial colony in 20µl of lysis buffer containing 0.25% SDS and 0.05 21 N NaOH, incubating at 95°C for 5 min, and then adding 180µl of sterile dH 2 O. After 22 centrifugation for 1 min at 16,100 x g to sediment the debris, the supernatant was used as 23 on August 29, 2017 by guest http://aac.asm.org/ Downloaded from 6 template DNA for PCR. Samples were kept at -20°C for long-term storage. PCRs were carried 1 out with a Mastercycler Gradient thermal cycler (Eppendorf, Westbury, NY). PCR amplification 2 of serp0107 was performed as previously described (16) using the primers listed in Table 1. The  3 presence of a single 581-bp product on 1% agarose gel electrophoresis was consistent with a 4 species identification of S. epidermidis. To confirm the identification, RFLP analysis of the 5
Staphylococcus tuf gene PCR product was performed, using the method described by Kontos and 6 colleagues (15). Briefly, PCR amplification of the tuf gene yielded a 370-bp amplicon that was 7 confirmed by gel electrophoresis on a 2% agarose gel (15). The product was extracted using a 8
QIAquick gel extraction kit (QIAGEN, Valencia, CA), according to the manufacturer's 9 instructions, and subjected to the BstZ17I, BseNI, and MseI restriction enzyme digestion. The 10 resulting fragment(s) were resolved by electrophoresis through a 3% agarose gel containing 11 ethidium bromide at 50V for 45 min and visualized under UV light. Digestion of the tuf gene 12 amplicon of S. epidermidis produces two fragment using BstZ17I (243-and 127-bp), three 13 fragment using , and no restriction using MseI (single 370-bp 14 product). The presence of these fragments positively identified the strain as S. epidermidis. Figure 1) were also tested. 4
Bacteria were grown overnight and suspended in fresh TSB to an OD 600 of 0.01 and 100 µl were 5 dispensed into wells with the first well containing 200 µl. NTZ and other antibiotics (DMSO 6 control) were added to well one and serially diluted from 32 µg/ml. All compounds were tested 7 in triplicate and plates were read visually or with a plate reader (Molecular Devices) at 8, 12 and 8 at 24 h. MIC was determined as the first well in which no visible bacterial growth was noted 9 relative to controls. The effects of accumulated biofilm was corrected for by transfer of 100 µl 10 aliquots to another microplate. Drug effects on aerobic growth were determined in 125 ml 11 flasks containing 25 ml of TSB medium and following inoculation (detailed above), flasks were 12 shaken on a gyrorotory shaker at 200 rpms at 37 o C. Final concentrations of NTZ were 0, 10 and 13 25 µg/ml and samples were removed at hourly intervals, diluted and turbidity was determined at 14 600 nm. 
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Following recording of turbidities, the culture medium was aspirated and the wells were 1 washed three times with distilled water, blotted on paper towels, and fixed with 75% ethanol for 2 10 minutes. To visualize biofilm material, 0.5% crystal violet was added to each well and after 5 3 minutes was removed and the wells washed three times with distilled water. Plates were read 4 using a microplate reader at 570 nm (Molecular Devices). The dye was then extracted by adding 5 200 µl of 95% ethanol, and the absorbance was read again at 570 nm. All assays were performed 6 in triplicate and the mean and standard deviation determined. Generally, the ethanol solubilized 7 crystal violet was more reliable and these determinations are reported throughout. 8
Catheter adherence model. An overnight culture of S. epidermidis 9142 was used to 9 inoculate fresh TSB medium to a final OD 600 of 0.01 in a volume of 3 ml in 15 ml screw capped 10 tubes. Sterile sheets of polyurethane were divided into 1 cm square pieces and placed into tubes 11 containing different concentrations of NTZ or controls containing DMSO. The tubes were 12 incubated for 24 h with shaking. Each catheter portion was washed 3 times with sterile PBS, 13 suspended in 4 ml sterile PBS and sonicated for 10 min in a sonic water bath. 10µl of the 14 sonicated fluid was diluted in fresh PBS and plated onto TSA plates and incubated at 37 o C 15 overnight. Bacteria were enumerated (triplicate plates) and the mean and standard deviation were 16 determined and reported as CFU/ml. Viability effects were corrected for by plating the 17 supernatants from the 3 ml experiment for total bacterial counts. rows contained NTZ (2.5, 5, 10, and 15 µg/ml). At 8 h, one plate was developed for biofilm 1 determination as described above, while the medium in the replicate plate was aspirated and 2 replaced with fresh TSB, with the first three rows now containing NTZ at 5, 10 and 15 µg/ml and 3 for the remaining wells, the same concentration of NTZ. These plates were developed at 24 h and 4 the relative amount of biofilm for each set compared. 5
Direct attachment assay. To determine if NTZ directly inhibited attachment of bacteria to 6 polystyrene, S. epidermidis strain 9142 was grown overnight in TSB medium with shaking in 7 125 ml flasks in the presence or absence of 15 µg/ml NTZ. In some experiments, overnight 8 growth was diluted to an OD 600 of 0.1 in fresh TSB medium and grown exponentially (shaking 9 or static and in the presence or absence of 15 µg/ml NTZ) for 3 h. In each condition, bacteria 10 were harvested by centrifugation and suspended in PBS to an OD 600 of 0.01 and 200 µl was 11 added to 6-well polystyrene microtiter plates (Nulcon, Nunc AIS. Denmark). After one hour 12 incubation at 4 and 37 o C, plates were washed with PBS (5x 5 ml) to remove non-adherent 13 bacteria and the adherent bacteria were visualized microscopically (directly or following staining 14 with crystal violet) with a Zeiss Axiovert 200 inverted microscope (Carl Zeiss Inc., Thornwood, 15 NY). The number of adherent bacteria per field (multiple fields) was video recorded and 16 analyzed using Image Pro Plus software (Media Cybernetics, Bethesda, MD). The means and SD 17
were computed from at least 3 wells and 3 multiple fields and analyzed statistically (t-test). 18
Effect of zinc on the action of NTZ. To assess whether ZnSO 4 or ZnCl 2 could overcome 19 the inhibitory action of NTZ on biofilm production, standard biofilm assays were established at 20 an NTZ concentration of 12.5 µg/ml, which is sufficient to abolish biofilm formation by S. 21 epidermidis strain 9142 (~ 2x IC 50 NTZ in solution, we tested a range of concentrations of both NTZ and TIZ and scanned the 8 solutions spectrophotometrically using an OLIS Cary-14 (OLIS Instruments Co., Bogart 9 Georgia). Absolute spectra were recorded over a UV/Vis range from 220 nm to 700 nm. Spectral 10 shifts in the 418 nm range would be attributable to changes in resonance within the thiazole ring 11 that would result if Zn 2+ were coordinated by NTZ (9). 12 1 H NMR. Chelation experiments were also performed utilizing NTZ and TIZ in DMSO-13 d 6 (0.5 mL) with ZnCl 2 using a 300 MHz Varian MercuryPlus spectrometer. Specifically, three 14 ratios of NTZ to Zn 2+ were investigated (1:1, 1:2, 2:1) where NTZ was held constant (4 mg, 13 15 µmoles) while varying ZnCl 2 (1.8 mg, 13 µmoles or 3.5 mg, 26 µmoles) or NTZ (8 mg, 26 16 µmoles) with ZnCl 2 (1.8 mg, 13 µmoles). Three ratios of TIZ to Zn 2+ were also investigated (1:1, 17 1:2, 2:1) where TIZ was held constant (4 mg, 15 µmoles) while varying ZnCl 2 (2.1 mg, 15 18 µmoles or 4.1 mg, 30 µmoles) or TIZ (8 mg, 30 µmoles) with ZnCl 2 (2.1 mg, 15 µmoles).
H 19
NMR spectra were then obtained after mixing for 5 min, 24 h, 48 h and 72 h at room 20 temperature. Any chelation event would be evidenced by shifting or broadening of the thiazole 21 and benzene protons as well as loss of the amide proton. 22 RESULTS 1 MIC testing of S. aureus and S. epidermidis strains. The inhibitory effect of NTZ on 2 staphylococcal strains was investigated first by determining MIC. Our studies showed that most 3 strains tested were susceptible to NTZ and TIZ with an MIC of 8-16 µg/ml (see Figure 2A) , 4 indicating these strains are generally more susceptible to this drug than previously reported (6). 5
In contrast to previous studies indicating the drug was active under anaerobic conditions (6), we 6 found NTZ and the active metabolite TIZ inhibited the growth of S. epidermidis in liquid culture 7 under vigorous aeration in a dose dependent manner with significant inhibition at 25 µg/ml (see 8 Figure 2B ). At lower drug concentrations (10 µg/ml), there was little effect on exponential 9 growth rates. Under static (microaerobic) growth conditions in liquid culture, biofilm 10 accumulation on the bottom of flasks was completely ablated by 10 µg/ml of NTZ, while final 11 bacterial turbidities were only slightly decreased when compared with drug-free controls (data 12 not presented). These observations suggest that sub inhibitory concentrations of NTZ may also 13 affect the production of biofilm. 14 NTZ inhibits biofilm production at sub-MIC levels. To further explore the sub-MIC 15 drug effects on biofilm accumulation, we screened several CoNS species for biofilm production. 16
As seen in Figure 2C , NTZ inhibited biofilm production by S. epidermidis strain 9142 and S. 17 haemolyticus strain 33208 in a dose dependent manner as determined by crystal violet staining. 18
Biofilm inhibition was not due to growth inhibition (see Fig. 2A ), although bacterial growth was 19 decreased at 8 and 16 µg/ml drug concentrations. The IC 50 was determined to be 1-3 µg/ml (~ 3-20 10 µM). Two additional strains tested (Fig. 2C) were non-biofilm producing strains. While not 21 depicted, the deacetylated form of NTZ (TIZ) gave equivalent results while the denitro form of 22 the drug did not inhibit biofilm production and exhibited an MIC >32 µg/ml (data not presented). Table 1 for details). As seen in 3 Figure 3A , NTZ inhibited biofilm formation by all clinical isolates that produced biofilm in the 4 absence of the drug in a dose dependent manner. Furthermore, NTZ inhibited biofilm formation 5 by the S. epidermidis strain 5179-R1 (see Fig 3B) , which generates a PNAG-independent, 6 protein-rich biofilm that is dependent on the production of a proteolytically processed derivative 7 of the Aap protein (30). For all strains tested, the IC 50 ranged between 1 and 5 µg/ml and the 8 MIC was 16 µg/ml. tested whether 10 µM zinc sulfate or zinc chloride might improve attachment of bacteria in the 5 presence of NTZ. Zinc salts (sulfate shown) had no effect on attachment (P = 0.49). Generally, 6 zinc add-back to putative apo-Aap protein should result in bacterial clumping which was not 7 observed in these experiments. These studies indicate that NTZ does not interfere with primary 8 attachment which appears to be independent of mechanisms associated with biofilm formation. 9 Does NTZ affect biofilm production by colonized bacteria? We next investigated whether 10 NTZ was inhibitory to biofilm production by established S. epidermidis communities. If NTZ is 11 a specific inhibitor of accumulation, the drug should inhibit further deposition of biofilm in 12 established communities. To test this hypothesis, we allowed S. epidermidis bacteria to establish 13 biofilm in the absence of drug for 4 h, and following washings to remove non-adherent bacteria, 14 NTZ (range of concentrations) was added in fresh TSB medium for an additional 12 h. As seen 15 in Figure 5 , the biofilm produced at 4 hr was ca 0.5 absorbance units by the crystal violet assay 16 and by the end of the assay; the accumulated biofilm had increased to 3 absorbance units in the 17 non-drug treated well. While biofilm also increased in the NTZ treated wells, there was a drug 18 dependent effect on further accumulation of biofilm material. However, drug treatment did not 19 eliminate the preformed biofilm indicating that NTZ was not dispersive. 20
Reversal of NTZ inhibition by zinc. Recent studies have shown that the surface proteins 21
Aap of S. epidermidis and SasG of S. aureus promote intercellular adhesion of staphylococcal 22 bacteria and that metal chelators like EDTA can inhibit biofilm production (4, 5, 13 Figure 6a , the addition of Zn 2+ to the standard biofilm assay reversed 6 the inhibitory action of NTZ in a dose dependent manner. While not depicted, EDTA also 7 inhibited biofilm production and similar to NTZ, could be reversed by zinc (4, 13). The effects of 8 Zn 2+ were specific as addition of other metals (calcium and magnesium) did not reverse the 9 inhibition (see Figure 6a) . While NTZ seems to achieve the same phenotype as treatment with 10 EDTA, we could not distinguish between NTZ acting directly as a Zn 2+ chelator or if NTZ was 11 bound to G5 domains. 12
NTZ and TIZ do not chelate Zn

2+
. To address whether Zn 2+ is directly chelated by NTZ 13 (TIZ) and alters potency of the drug, we scanned putative NTZ/TIZ-Zn 2+ coordination 14 complexes for any spectral changes that might result from changes in ring resonance due to 15 bound ligand. Based on NMR studies, the anionic form of NTZ exists in several resonance states 16 that exist simultaneously for the amino thiazole moiety which contributes to the absorption 17 maxima at 418 nm (9). Metal coordination would be predicted to alter resonance and this should 18 manifest in a spectral shift. Spectral scans performed at different concentrations of NTZ and TIZ 19 with Zn 2+ did not reveal any changes in absorption spectrum (data not presented). To further 20 explore NTZ metal interactions, putative NTZ and TIZ complexes with Zn +2 were analyzed by 21 throughout the course of the experiment. Tizoxanide also displayed no chelation with ZnSO 4 1 under the experimental conditions. Taken together, these studies indicate that these drugs did not 2 chelate zinc under these assay conditions. 3
Effect of Zn
2+ on bacterial growth. To test the possibility that the action of Zn 2+ on 4 ablation of biofilm by NTZ might result from reversal of the growth inhibitory effect of the drug, 5 bacterial turbidities at 16 h were determined at a fixed concentration of NTZ of 12.5 µg/ml. As 6 seen in Figure 6b , Zn 2+ enhances the growth of S. epidermidis strain 9142 in a dose dependent 7 manner. MIC testing at a fixed concentration of Zn 2+ (10 µM) showed a shift from 16 µg/ml to 8 32 µg/ml (data not presented). We also noted that Zn 2+ supplementation of TSB medium 9 improved bacterial growth as indicated by slightly higher final turbidities at 16 h (A 600 of 0.65 10 for controls to 0.82 with Zn 2+ ). To test whether enhanced growth might lead to breakthrough, we 11 repeated MIC experiments over a shorter period. Zn 2+ had no effect on the inhibitory action of 12 NTZ up to 10 h, suggesting that zinc might affect other bacterial systems unrelated to biofilm 13 production that promote breakthrough growth, thus contributing to biofilm production. It should 14 be noted that similar studies with sub-MIC levels of vancomycin showed no effect by zinc (data 15 not presented). 16
Hydrophobicity effects. NTZ is hydrophobic and sparingly soluble in water and its 17 deacylated form (TIZ) is 97.5% bound to plasma proteins (34). It is possible therefore, that the 18 action of the drug is nonspecific and results from binding onto surface proteins and ablating their 19 action. To test this possibility we synthesized a more soluble derivative of NTZ (AMIX) by 20 adding an ethylamine R group to the benzene ring of TIZ. The drug retained bioactivity with an 21 MIC of 16-32 µg/ml. This derivative was soluble at 400 µg/ml in water (NTZ < 32 µg/ml) and as 22 seen in Figure 7 exhibited a slightly higher IC 50 than NTZ (8 versus 4 µg/ml, respectively in this 23
on August 29, 2017 by guest http://aac.asm.org/ Downloaded from experiment). The 2-fold difference in biofilm inhibition was less than the 15-fold difference in 1 solubility. Taken together, these studies suggest that the action of NTZ in blocking accumulation 2 and biofilm production is most likely specific. 3 4 DISCUSSION 5
We have determined that the antiparasitic drug nitazoxanide and its active metabolite 6 tizoxanide are inhibitory to in vitro growth of various staphylococcal species, including MRSA 7 strains of S. aureus. This contrasts with an earlier report that TIZ was not active against 8 staphylococci and that the action of NTZ was limited to anaerobic growth conditions (6). In the 9 current study we demonstrated that NTZ inhibited growth of S. epidermidis strain 9142 in highly 10 aerated broth cultures at 25 µg/ml, but little inhibition was observed at concentrations at or 11 below 10 µg/ml. We found NTZ to be slightly more active than TIZ by MIC tests which might 12 be attributed to slight differences in solubility, while the de-nitro NTZ was biologically inert. 13
Our studies further demonstrate that at sub-MIC concentrations (1 -5 µg/ml), NTZ and TIZ 14 inhibited production of biofilm in a static microtiter plate assay. Under static conditions in flasks, 15 NTZ ablated biofilm production at 10 µg/ml with only a slight decrease in final bacterial 16 turbidity and there was no discernable difference in primary attachment to plastic. In comparison 17 with untreated bacteria, NTZ-treated bacteria did not clump and appeared more dispersed by 18 microscopic examination. The anti-biofilm activity of NTZ could be reversed by zinc salts (IC 50 19 = 5 µM), but not by Ca 2+ or Mg 2+ and was growth dependent. The zinc effect seems to be unique 20 to NTZ and TIZ as zinc had no effect on the sub-MIC action of vancomycin on growth or 21 biofilm formation. The possibility that zinc inactivated NTZ or formed chelates could not be 22 demonstrated by optical spectrophotometry or by NMR. 23
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One possible candidate for the action of NTZ is the zinc-dependent associative adhesion 1 protein (Aap) that has been extensively studied and recently shown to mediate intercellular 2 adhesion of S. epidermidis on surfaces (4). In this regard, purified Aap protein monomers 3 associated into aggregates in the presence of Zn 2+ and this association was mediated by G5 4 domains through formation of zinc zippers (4). The Aap target was initially considered because 5 NTZ inhibited biofilm production by S. epidermidis strain 5179-R1, which only produces a 6 proteinaceous biofilm composed of Aap (30). However, we found no evidence for chelation of 7
Zn
2+ by NTZ, as is the case for the anti-biofilm action of EDTA and other metal chelators or by 8 low pH (4, 13). Similarly NTZ does not appear to de-metal Aap surface proteins; since zinc add-9 back experiments to NTZ-grown bacteria did not restore spontaneous aggregation (clumping) of 10 bacteria in solution that is attributed to Aap (4). While the absence of Aap function might 11 suggest that NTZ affects aap gene expression or a later step in assembly of Aap, we could not 12 rule out the possibility that these hydrophobic drugs might bind nonspecifically to surface 13 components. 14 To address the possibility of nonspecific binding to surface proteins, polysaccharides or 15 teichoic acids through hydrophobic or ionic interactions (38), we tested a more hydrophilic 16 derivative of NTZ (AMIX) and found similar inhibitory anti-biofilm action. These studies lead 17 us to suggest that NTZ affects either the regulation of biofilm gene expression (aap and ica) or 18 Coating catheters with antimicrobial agents has been shown to delay or prevent microbial 3 colonization and to extend their useful lifespan (1, 3, 13, 20) . In simulated catheter experiments 4 under growth promoting conditions, we showed that NTZ blocked the attachment or more likely 5 the accumulation of bacteria onto catheter surfaces, but did not display any biofilm dispersive 6 activity. The prevention of further accumulation is consistent with the postulate that the drug 7 affects biofilm production in general. While NTZ has poor pharmacologic properties, it is likely 8 that less hydrophobic derivatives, such as AMIX, might prove more efficacious in treating 9 systemic infections. AMIX is less toxic (than NTZ) to staphylococci by MIC testing while 10 retaining antibiofilm activity. Moreover, the inhibitory action of AMIX was not reversed by 11 Zn 2+ salts, raising the possibility that the noted effects of Zn 2+ on NTZ potency might be related 12 to drug uptake or efflux activities, where differences in hydrophobicity would likely manifest. 13
The primary attachment to and accumulation of microorganisms on surfaces is an essential 14 step in the infection process and conceptually, targeting these requisite virulence determinants 15 might provide an additional strategy for limiting or reducing the severity of infections. Our 16 findings extend early observations of Dubreuil et al by demonstrating that NTZ and derivatives 17 are more potent against staphylococcal species including MRSA strains under aerobic as well as 18 microaerobic conditions than previously considered (6). Since we have synthesized derivatives 19 of NTZ in which the MIC and IC 50 are the same (~ 1 µg/ml), and assuming target is unchanged, 20 we suggest that NTZ must target an essential function where measured differences between MIC 21 and IC 50 can be explained by relative affinities of the drug for its target. fresh medium and grown for 3 hr (with our without shaking). Bacteria were suspended in PBS to 4 OD 600 of 0.1 and 1 ml was added to 6 well plates as described in the text. Nitazoxanide (NTZ) 5 was added to wells at 15 µg/ml and ZnSO 4 was added at 10 µM. Adherent bacteria were 6 enumerated microscopically and mean and SD computed from multiple fields of triplicates. Data 7 were analyzed by one tail t-test. None of the listed P values was considered significant. 
